Skip to content

Jazz Pharmaceuticals JAZZ Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions

Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$0-100%

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions?
Jazz Pharmaceuticals (JAZZ) reported unrecognized tax benefits, decrease resulting from prior period tax positions of $162K in Q4 2025.
How has Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions changed year-over-year?
Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions increased by 332.0% year-over-year, from $37.5K to $162K.
What is the long-term trend for Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions?
Over 4 years (2021 to 2025), Jazz Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions has grown at a 37.4% compound annual growth rate (CAGR), from $182K to $648K.
What does unrecognized tax benefits, decrease resulting from prior period tax positions mean?
The reduction in tax uncertainty regarding historical tax filings.
How do you interpret unrecognized tax benefits, decrease resulting from prior period tax positions?
A decrease generally signals the resolution of tax uncertainties, which can lead to a favorable impact on the effective tax rate.
How does unrecognized tax benefits, decrease resulting from prior period tax positions compare across companies?
Standard reconciliation item in tax footnotes; investors look for consistent decreases as a sign of effective tax risk management.